Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China

The First Hospital of Jilin University8,476 enrolled

Overview

The investigators sought to identify and verify the potential correlates and mechanisms of Very Late Stent Thrombosis (VLST) after the implantation of new generation drug eluting steng in China from an analysis of multicenter registries.

This study represents a patient-level pooled analysis of patients undergoing percutaneous coronary intervention with stent implantation for acute coronary syndrome. Multiple aspects including clinical, angiographic, procedural characteristics , intravascular imaging results and blood samples were collected at index PCI and the time of VLST or CAG during follow-up, in order to reveal the potential mechanisms or risk factors that contribute to the development of VLST.

Study Type

OBSERVATIONAL

Enrollment

8,476

Conditions

Stent Thrombosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients\>18y,admitted for acute coronary syndrome,successfully underwent PCI with at least one stent, sign informed consent. Exclusion Criteria: * Expected lifetime was less than 1 year for any severe disease(such as tumor,severe respiratory failure et al). There is a surgical plan for important organs within 1 year after surgery and anti-platelet drugs should be discontinued. Refusing to sign informed consent.Died prior to discharge. Poor compliance, unable to participate in regular follow-up.

Locations (1)

Jilin University 1st Hospital

Changchun, Jilin, China

Outcomes

Primary Outcomes

Very Late Stent Thrombosis

very late stent thrombosis demonstrated by coronary angiography

Time frame: Five years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.